Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

China Looks At Innovation, Quality Policies As Chronic Diseases Rise

This article was originally published in The Pink Sheet Daily

Executive Summary

Maximizing innovation and focusing on product quality should be prioritized in China’s next Five-Year Plan for the pharma industry, representatives proposed at a recent government meeting. Meanwhile, data from the national health regulator have indicated a sharp rise in chronic diseases and obesity in the country.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register